First Time Loading...

Capitol Health Ltd
ASX:CAJ

Watchlist Manager
Capitol Health Ltd Logo
Capitol Health Ltd
ASX:CAJ
Watchlist
Price: 0.24 AUD Market Closed
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one CAJ stock under the Base Case scenario is 0.66 AUD. Compared to the current market price of 0.24 AUD, Capitol Health Ltd is Undervalued by 63%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CAJ Relative Value
Base Case
0.66 AUD
Undervaluation 63%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.1
P/S
P/S
Price to Sales
1.1
vs History
73
vs Industry
66
Median 3Y
1.7
Median 5Y
1.5
Industry
2.4
Forward
1.1
More Details
41.6
P/E
P/E
Price to Earnings
41.6
vs History
22
vs Industry
11
Median 3Y
27.9
Median 5Y
25.7
Industry
23.2
Forward
22.6
More Details
7
P/OCF
P/OCF
Price to OCF
7
vs History
68
vs Industry
43
Median 3Y
8.9
Median 5Y
8.4
Industry
15.5
More Details
14.5
P/FCFE
P/FCFE
Price to FCFE
14.5
vs History
31
vs Industry
29
Median 3Y
9.4
Median 5Y
7.4
Industry
23.5
More Details
1.9
P/B
P/B
Price to Book Value
1.9
vs History
47
vs Industry
44
Median 3Y
2.1
Median 5Y
1.9
Industry
2.2
More Details
1.6
EV/S
EV/S
Enterprise Value to Sales
1.6
vs History
68
vs Industry
55
Median 3Y
2.1
Median 5Y
1.9
Industry
2.5
Forward
1.5
More Details
1.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.7
vs History
68
vs Industry
72
Median 3Y
2.3
Median 5Y
2.1
Industry
5.2
More Details
21.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21.3
vs History
28
vs Industry
15
Median 3Y
20
Median 5Y
19
Industry
12.5
Forward
7.6
More Details
21.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21.3
vs History
28
vs Industry
22
Median 3Y
20
Median 5Y
19
Industry
17.2
Forward
17.1
More Details
10.2
EV/OCF
EV/OCF
Enterprise Value to OCF
10.2
vs History
55
vs Industry
37
Median 3Y
10.6
Median 5Y
10.6
Industry
15.1
More Details
31.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
31.8
vs History
20
vs Industry
17
Median 3Y
17
Median 5Y
19.2
Industry
19.7
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
55
vs Industry
51
Median 3Y
1.6
Median 5Y
1.4
Industry
2
More Details

Multiples Across Competitors

CAJ Competitors Multiples
Capitol Health Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Capitol Health Ltd
ASX:CAJ
255.6m AUD 1.1 41.6 21.3 21.3
US
Cigna Group
XMUN:CGN
96.6B EUR 0.5 20 10.3 13.7
US
Cigna Corp
NYSE:CI
103.7B USD 0.5 20.1 10.3 13.8
US
CVS Health Corp
NYSE:CVS
86.5B USD 0.2 10.4 8.9 8.9
DE
Fresenius Medical Care AG
XMUN:FME
22.2B EUR 1.1 44.4 10.4 24.6
US
Laboratory Corporation of America Holdings
NYSE:LH
16.7B USD 1.4 38.6 11.8 17.7
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.3B EUR 0.7 -25.8 9.9 22.2
US
Quest Diagnostics Inc
NYSE:DGX
14.9B USD 1.6 17.7 10.6 14.2
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11B EUR 0.6 22 6.7 15.9
US
DaVita Inc
NYSE:DVA
11.9B USD 1 17.1 8.4 12.3
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
CAJ intrinsic value, competitors valuation, and company profile.
DCF Valuation
CAJ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CAJ stock valuation using valuation multiples.
Wall Street Estimates
CAJ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CAJ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.